The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study^*

References

• Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 2014;259:449–57.
   PubMed Web of Science ®Google Scholar
• Chari A, Clemente Morgado T, Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2014;28:2–7.
   PubMed Web of Science ®Google Scholar
• Kudo H, Kuwamura K, Izawa I, et al. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 1992;32:207–9.
   PubMedGoogle Scholar
• Dumont TM, Rughani AI, Goeckes T, Tranmer BI. Chronic subdural hematoma: a sentinel health event. World Neurosurg 2013;80:889–92.
   PubMed Web of Science ®Google Scholar
• Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 2011;114:72–6.
   PubMed Web of Science ®Google Scholar
• Weigel R. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 2003;74:937–43.
   PubMed Web of Science ®Google Scholar
• Chan DYC, Woo PYM, Poon WS. Chronic subdural hematoma: to drain or not to drain, this is the question. World Neurosurg Elsevier 2014;82:1007–9.
   PubMed Web of Science ®Google Scholar
• Kalamatianos T, Stavrinou LC, Koutsarnakis C, et al. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. J Neurosurg 2013;118:1–5.
   PubMed Web of Science ®Google Scholar
• Stanisic M, Aasen AO, Pripp AH, et al. Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res. SP Birkhäuser Verlag Basel 2012;61:845–52.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Ohno K. Chronic subdural hematoma - an up-to-date concept. J Med Dent Sci 2013;60:55–61.
   PubMedGoogle Scholar
• Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004;100:24–32.
   PubMed Web of Science ®Google Scholar
• Drapkin AJ. Chronic subdural hematoma: pathophysiological basis for treatment. Br J Neurosurg 1991;5:467–73.
   PubMedGoogle Scholar
• Chan DYC, Sun TFD, Poon WS. Steroid for chronic subdural hematoma? A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation. Chinese Neurosurg J 2015;1:2.
   Google Scholar
• Sun TFD, Boet R, Poon WS. Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone. Br J Neurosurg 2005;19:327–33.
   PubMed Web of Science ®Google Scholar
• Wang D, Li T, Wei H, et al. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model. J Neurol Sci. Elsevier BV 2016;362:91–9.
   PubMed Web of Science ®Google Scholar
• Araújo FA, Rocha MA, Mendes JB, Andrade SP. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother 2010;64:29–34.
   PubMed Web of Science ®Google Scholar
• Verschuren L, Kleemann R, Offerman EH, et al. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 2005;25:161–7.
   PubMed Web of Science ®Google Scholar
• Wang D, Jiang R, Liu L, et al. Membrane neovascularization and drainage of subdural hematoma in a rat model. J Neurotrauma 2010;27:1489–98.
   PubMed Web of Science ®Google Scholar
• Li T, Wang D, Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats. J Neurol Sci 2014;341:88–96.
   PubMed Web of Science ®Google Scholar
• Wang D, Li T, Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers. J Neurol Sci Elsevier BV 2014;336:237–42.
   PubMed Web of Science ®Google Scholar
• Sucu HK, Gokmen M, Gelal F. The value of XYZ/2 technique compared with computer-assisted volumetric analysis to estimate the volume of chronic subdural hematoma. Stroke 2005;36:998–1000.
   PubMed Web of Science ®Google Scholar
• Riad A, Du J, Stiehl S, et al. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. Eur J Pharmacol 2007;569:204–11.
   PubMed Web of Science ®Google Scholar
• Lewandowski M, Kornacewicz-Jach Z, Millo B, et al. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. Cardiol J 2008;15:357–64.
   PubMedGoogle Scholar
• Gottsäter A, Flondell-Site D, Kölbel T, Lindblad B. Associations between statin treatment and markers of inflammation, vasoconstriction, and coagulation in patients with abdominal aortic aneurysm. Vasc Endovascular Surg 2009;42:567–73.
   Web of Science ®Google Scholar
• Schrott H, Fereshetian AG, Knopp RH, et al. A Multicenter, Placebo-Controlled, Dose-Ranging Study of Atorvastatin. J Cardiovasc Pharmacol Ther 1998;3:119–23.
   PubMedGoogle Scholar
• Jiang R, Wang D, Poon WS, et al. Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial. Trials Trials 2015;16:528.
   PubMed Web of Science ®Google Scholar